2025-08-25 - Analysis Report
Okay, here's a comprehensive analysis of Natera Inc. (NTRA) based on the provided data, presented in English with a focus on key figures and their implications.

## NTRA (Natera Inc) Stock Analysis

**Company Overview:** Natera Inc is a diagnostics company focused on genetic testing for reproductive health, oncology, and organ health.

### 1. Performance vs. S&P 500 (VOO)

*   **NTRA Cumulative Return:** 148.88%
*   **VOO Cumulative Return:** 99.52%
*   **Absolute Divergence:** 49.36%
*   **Relative Divergence:** 13.2%

**Analysis:** NTRA has significantly outperformed the S&P 500 over the analyzed period.  The current divergence is positioned relatively low compared to its historical range, which may suggest some room for continued relative outperformance, but should be viewed with caution considering recent volatility.

### 2. Alpha/Beta Analysis

| Year       | CAGR   | MDD   | Alpha   | Beta | Cap (B) |
|------------|--------|-------|---------|------|---------|
| 2015-2017  | -6.0%  | 62.4% | -31.0%  | 0.0  | 1.2     |
| 2016-2018  | 29.0%  | 80.1% | 11.0%   | 0.0  | 1.9     |
| 2017-2019  | 159.0% | 80.1% | 130.0%  | 1.2  | 4.6     |
| 2018-2020  | 530.0% | 80.1% | 510.0%  | 0.3  | 13.7    |
| 2019-2021  | 355.0% | 62.9% | 307.0%  | 0.2  | 12.8    |
| 2020-2022  | -119.0%| 62.9% | -121.0% | 0.2  | 5.5     |
| 2021-2023  | -482.0%| 69.9% | -500.0% | 1.1  | 8.6     |
| 2022-2024  | -75.0% | 70.6% | -100.0% | 1.2  | 21.7    |
| 2023-2025  | 98.0%  | 76.1% | 47.0%   | 0.8  | 22.1    |

**Analysis:**

*   **CAGR:**  Shows highly variable annual growth, indicating periods of both explosive gains and significant losses. The most recent period (2023-2025) shows a positive, but moderate return.
*   **MDD (Maximum Drawdown):**  High MDD figures across all periods demonstrate significant downside risk.
*   **Alpha:**  Indicates NTRA's performance relative to its benchmark. Large positive alphas in some periods (e.g., 2018-2020, 2019-2021) indicate substantial outperformance, while negative alphas signal underperformance.
*   **Beta:** Fluctuates, indicating variable market sensitivity.
*   **Cap (B):** Market Cap has been growing over time.

### 3. Recent Price Action & Moving Averages

*   **Last Price:** 160.64
*   **Last Market Data:** Price: 165.6, Previous Close: 161.95, Change: 2.25
*   **5-day MA:** 160.67
*   **20-day MA:** 147.44
*   **60-day MA:** 156.00

**Analysis:**

*   The recent price of 165.6 is above the 5-day, 20-day, and 60-day moving averages, suggesting a short-term upward trend.  The increase of 2.25 from the previous close also supports this.

### 4. Technical Indicators

*   **MRI (Market Risk Indicator):** 0.3316 (Low Risk)
*   **RSI:** 82.92 (Overbought)
*   **PPO:** 1.68
*   **Hybrid Signal:** Buy 90% of cash
*   **Delta_Previous_Relative_Divergence:** 1.0 (+) (Short-term increase)
*   **Expected Return:** 108.9% (Long-term, S&P 500 outperformance)

**Analysis:**

*   **MRI:** Suggests a low level of market risk.
*   **RSI:** Indicates that the stock is currently overbought, potentially signaling a pullback.
*   **PPO:**  Positive, suggesting upward momentum, but needs to be evaluated in the context of the overbought RSI.
*   **Delta_Previous_Relative_Divergence:**  Reinforces the short-term upward trend.
*   **Expected Return:**  High expected return suggests optimism for long-term outperformance.

### 5. Recent News & Significant Events

*   **2025-08-24:** Major business developments, regulatory changes, or market events.
*   **2025-08-25:** Analysts discussing performance and outlook.
*   **2025-08-21:** Notable stock volatility.
*   **2025-08-23:** Experts highlighting risks and opportunities.

**Analysis:**  The news snippets point to active developments, potential catalysts, and volatility. Investors should monitor specific company announcements and analyst reports to understand the underlying drivers.

### 6. Recent Earnings Analysis

| 날짜       | EPS   | 매출      |
|------------|-------|-----------|
| 2025-08-08 | -0.74 | 0.55 B$   |
| 2025-05-09 | -0.5  | 0.50 B$   |
| 2024-11-12 | -0.26 | 0.44 B$   |
| 2024-08-09 | -0.3  | 0.41 B$   |
| 2025-08-08 | -0.3  | 0.41 B$   |

**Analysis:**

*   **EPS:** Negative EPS values indicate that the company is currently not profitable.
*   **Revenue:** Revenue has generally been increasing, suggesting growth in the company's operations.

### 7. Financial Information

**Revenue and Profitability:**

| Quarter      | Revenue | Profit Margin |
|--------------|---------|---------------|
| 2025-06-30   | $0.55B  | 63.41%        |
| 2025-03-31   | $0.50B  | 63.12%        |
| 2024-12-31   | $0.48B  | 62.94%        |
| 2024-09-30   | $0.44B  | 61.79%        |
| 2024-06-30   | $0.41B  | 58.83%        |

**Capital and Profitability:**

| Quarter      | Equity  | ROE      |
|--------------|---------|----------|
| 2025-06-30   | $1.25B  | -8.10%   |
| 2025-03-31   | $1.24B  | -5.40%   |
| 2024-12-31   | $1.20B  | -4.50%   |
| 2024-09-30   | $0.88B  | -3.60%   |
| 2024-06-30   | $0.84B  | -4.48%   |

**Analysis:**

*   **Revenue:** Increasing revenue over the quarters indicates business growth.
*   **Profit Margin:** High and relatively stable profit margins suggest efficient operations despite the lack of overall profitability.
*   **Equity:** Increasing equity suggests strengthening financial position.
*   **ROE:** Negative ROE values are consistent with the negative EPS, indicating that the company is not generating profits on its equity.

### 8. Overall Summary

NTRA presents a mixed picture:

*   **Strengths:**
    *   Significant historical outperformance relative to the S&P 500.
    *   Strong revenue growth and high profit margins.
    *   Low Market Risk Indicator.
    *   Positive short-term price momentum.
    *   High expected future returns.
*   **Weaknesses:**
    *   High historical volatility and maximum drawdowns.
    *   Currently overbought (RSI).
    *   Negative EPS and ROE, indicating current lack of profitability.
*   **Considerations:**
    *   Recent news suggests potential catalysts and ongoing volatility.
    *   The low Relative Divergence suggests possible opportunity for continued outperformance, but must be viewed in context of overbought conditions.

**Conclusion:**

NTRA is a high-growth, high-risk stock. The company shows promise with strong revenue growth and high profit margins, but its lack of profitability and high volatility require careful consideration. The recent overbought conditions suggest caution in the short term, but the long-term expected return remains attractive. Investors should closely monitor upcoming news and earnings reports to assess the company's progress towards profitability.
